Posted by Michael Wonder on 21 Apr 2022
ICER to assess treatments for multiple sclerosis
21 April 2022 - Report will be subject of New England CEPAC meeting in January 2023; draft scoping document open to public comment until 12 May 2022.
The ICER announced today that it will assess the comparative clinical effectiveness and value of treatments for multiple sclerosis.
